1.3 million people worldwide die every year from cancer’s deadliest form, lung cancer. The disease is deadly because it is detected and acted upon too late to enable life-saving and life-extending treatment. If diagnosed early, the long and eventful wait for radiologically established risk of malignancy could be reduced or eliminated, patients would have earlier access to therapy, and the 5 year survival rate could soar from 16% to 80%. The Freshmedx CB Test saves and extends lives by providing physicians with immediate and accurate information used to avoid unnecessary waiting, patient anxiety, costly procedures and reduced exposure to additional radiation.